Vast majority of ophthalmologists treating uveal melanoma use molecular testing to guide patient care
Today Topics ,
Castle Biosciences Inc. has announced the publication of study results that assess current clinical practices for uveal…
Castle Biosciences Inc. has announced the publication of study results that assess current clinical practices for uveal…
Prognostic tumor analysis results directly impact patient care plans Published in Clinical Ophthalmology Castle Biosciences Inc.